image credit: Freepik

3 ways decentralized clinical trials could help advance research on rare diseases

November 13, 2023

Pandemic-era changes may have permanently altered the clinical trial landscape as decentralized clinical trials gain broader acceptance. During COVID-19, more than three-quarters (76%) of pharmaceutical companies, device manufacturers and contract research organizations conducted off-site clinical trials. These types of trials specifically provide increased opportunity for individuals with rare diseases to participate as they reduce numerous barriers of traditional trials.

Read More on Biopharma Dive